Acceptance of the IBSC approval for seeking permission to manufacture test items for examination, test and analysis through form CT-10 as per the recommendation of the 314th RCGM meeting, dated 09.07.2025

Posted by: Hitesh Gupta September 11, 2025

7
Comments Off on Acceptance of the IBSC approval for seeking permission to manufacture test items for examination, test and analysis through form CT-10 as per the recommendation of the 314th RCGM meeting, dated 09.07.2025
11th September, 2025

What's New 2?

Regulation/Guidelines

Preparing for CDSCO Inspection: Documentation, Site Readiness, and Common Reasons for Delay

A CDSCO inspection is one of the most consequential events in a Medical Device company's regulatory journey in India. Whether you are a manufacturer or Importer, demonstrating compliance with the...

14th July, 2026

Regulation/Guidelines

Stem Cell Regulation in India: Separating Legitimate Therapy Development from Regulatory Risk

Introduction Stem cell therapy represents one of the most scientifically promising and regulatorily complex frontiers in modern medicine. India's stem cell regulatory landscape presents both genuine opportunity and significant compliance...

10th July, 2026

Regulation/Guidelines

Cosmetic Labelling in India: CDSCO, , and Legal Metrology — Three Bodies, One Label

Three Regulatory Bodies, One Physical Label A Cosmetic label entering India is reviewed — directly or through market surveillance — against the requirements of three separate regulatory frameworks: CDSCO's Cosmetics...

8th July, 2026

Regulation/Guidelines

New Medical Device in India: When MD-22, MD-23, MD-26, and MD-27 Apply

India's Medical Devices Rules, 2017 (MDR 2017) has a distinct regulatory pathway for Devices classified as New Medical Devices — a category that carries additional scrutiny, documentation requirements, and in...